Literature DB >> 15897044

Superficial acral fibromyxoma.

O Quaba1, A Evans, A A Al-Nafussi, A Nassan.   

Abstract

Superficial acral fibromyxoma is a rare soft tissue tumour affecting the digits, particularly the nail bed region. The condition was first described in 2001. We report the case of a 71-year-old man who presented with a long standing history of a lump affecting the pulp of the his right ring finger. This was surgically excised and subsequent pathological analysis confirmed the lesion to have been a superficial acral fibromyxoma. We use this case to highlight the features of this rare clinical entity, which has never previously been described in the surgical literature.

Entities:  

Mesh:

Year:  2005        PMID: 15897044     DOI: 10.1016/j.bjps.2004.03.006

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  5 in total

1.  A case of recurrent superficial acral fibromyxoma.

Authors:  Jawoong Goo; Ye-Jin Jung; Jae-Hong Kim; Sung-Yul Lee; Sung Ku Ahn
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

2.  Superficial Acral Fibromyxoma: Clinicopathologic Analysis of Five Cases.

Authors:  Soumiya Chiheb; Maha Mouradi; Fouzia Hali
Journal:  Skin Appendage Disord       Date:  2021-08-06

Review 3.  Superficial Acral Fibromyxoma involving the nail's apparatus. Case report and literature review.

Authors:  Ana Márquez García; Francisco Manuel Ildefonso Mendonça; Manuel Perea Cejudo; Francisco M Camacho Martínez; Juan José Ríos Martín
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

4.  Superficial Acral Fibromyxoma: Literature Review.

Authors:  Bruno Eiras Crepaldi; Ruan Dalbem Soares; Fábio Duque Silveira; Raul Itocazo Taira; Celso Kiyoshi Hirakawa; Marcelo Hide Matsumoto
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2019-10-29

5.  Superficial acral fibromyxoma on the tip of the big toe: expression of CD10 and nestin.

Authors:  N Misago; T Ohkawa; T Yanai; Y Narisawa
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-02       Impact factor: 6.166

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.